Question to the Department of Health and Social Care:

To ask His Majesty's Government what measures they are taking to support integrated care boards during the transition of COVID-19 treatments to routine pathways and to ensure equitable access across England.

The Government has made available a range of treatment options for eligible hospitalised and non-hospitalised patients with COVID-19 and the NHS will continue to deliver treatment for COVID-19 patients in line with evidence-based recommendations from National Institute for Health and Care Excellence.

Integrated care boards (ICBs) are responsible for the continued delivery of COVID-19 treatments, including where appropriate transitioning the delivery of community-based COVID-19 treatments away from COVID-19 Medicine Delivery Units to routine care pathways by the end of this month. ICBs have the flexibility to create a routine patient access pathway that best meets local needs and circumstances, including for immunocompromised patients. NHS England is working closely with local health systems and supporting ICBs to develop service delivery plans.